After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?

CVS Health (NYSE: CVS) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in 2024, when its shares nose-dived by 43%.Investors may have gotten lured into its low, attractive valuation or bought it for its high-yielding dividend, only to end up disappointed later on. The healthcare company, despite its broad diversification, hasn't provided investors with much safety at all; if you had held the stock for the past three years, your investment would have lost more than half its value.The company has recently made a change in management and is potentially looking at a myriad of options, including perhaps breaking up the business into smaller parts.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool